Renibus Therapeutics

Renibus Therapeutics is a developer of drugs for the treatment of acute kidney injury and chronic kidney disease. The company's portfolio includes: RBT-1, for the prevention of acute kidney injury; RBT-2, for the treatment of chronic kidney disease; and RBT-3, for the treatment of iron deficiency anemia and platinum-induced nephrotoxicity.